Role of nutritional factors at the early life stages in the pathogenesis and clinical course of type 1 diabetes

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Kagohashi, Yukiko ^a   Otani, Hiroki ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; AUTOANTIBODY; FATTY ACID; INSULIN;

DISEASE COURSE; ENVIRONMENTAL FACTOR; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LACTATION; NONHUMAN; NUTRITION; PATHOGENESIS; PREGNANCY; PROGENY; REVIEW; ANIMAL; ANIMAL FOOD; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 1; DIET; DISEASE MODEL; ENVIRONMENT; FEMALE; MATERNAL NUTRITION; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PATHOPHYSIOLOGY; PRENATAL EXPOSURE;

ANIMALIA; MUS;

ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DIET; DISEASE MODELS, ANIMAL; ENVIRONMENT; FATTY ACIDS; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; INSULIN; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICE; MICE, INBRED NOD; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84927144561     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/382165     Document Type: Review

References (64)

1. M. A. Atkinson and N. K. MacLaren, "Thepathogenesis of insulindependent diabetes mellitus", The New England Journal of Medicine, vol. 331, pp. 1428-1436, 1994.
2. G. S. Eisenbarth, "Type I diabetes mellitus. A chronic autoimmune disease", The New England Journal of Medicine, vol. 314, no. 21, pp. 1360-1368, 1986.
3. R. Tisch and H. McDevitt, "Insulin-dependent diabetes mellitus", Cell, vol. 85, no. 3, pp. 291-297, 1996.
4. N. Nokoff and M. Rewers, "Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals", Annals of the New York Academy of Sciences, vol. 1281, no. 1, pp. 1-15, 2013.
5. K. L. Mehers and K. M. Gillespie, "The genetic basis for type 1 diabetes", British Medical Bulletin, vol. 88, no. 1, pp. 115-129, 2008.
6. F. M. Egro, "Whyis type 1 diabetes increasing?" Journal of Molecular Endocrinology, vol. 51, no. 1, pp. R1-R13, 2013.
7. T. Hanafusa and A. Imagawa, "Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners", Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 1, pp. 36-45, 2007.
8. I. Spagnuolo, A. Patti, G. Sebastiani, L. Nigi, and F. Dotta, "The case for virus-induced type 1 diabetes", Current Opinion in Endocrinology, Diabetes and Obesity, vol. 20, no. 4, pp. 292-298, 2013.
9. S. Skarsvik, J. Puranen, J. Honkanen et al., "Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes", Diabetes, vol. 55, no. 4, pp. 996-1003, 2006.
10. M. Lönnrot, K. Salminen, M. Knip et al., "Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group", Journal of Medical Virology, vol. 61, no. 2, pp. 214-220, 2000.
11. R. Iwakiri, S. Nagafuchi, E. Kounoue et al., "Cyclosporin A enhances Streptozocin-induced diabetes in CD-1 mice", Experientia, vol. 43, no. 3, pp. 324-327, 1987.
12. A. A. Carter, T. Gomes, X. Camacho, D. N. Juurlink, B. R. Shah, and M. M. Mamdani, "Risk of incident diabetes among patients treated with statins: population based study", British Medical Journal, vol. 346, no. 7911, Article ID f2610, 2013.
13. A. D. Bolzán and M. S. Bianchi, "Genotoxicity of Streptozotocin", Mutation Research, vol. 512, no. 2-3, pp. 121-134, 2002.
14. M. Nakamura, S. Nagafuchi, K. Yamaguchi, and R. Takaki, "The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice", Diabetes, vol. 33, no. 9, pp. 894-900, 1984.
15. R. Iwakiri and S. Nagafuchi, "Inhibition of streptozocininduced insulitis and diabetes with lobenzarit in CD-1 mice", Diabetes, vol. 38, no. 5, pp. 558-561, 1989.
16. K. B. Johnsen, T. M. Poulsen, B. Z. Christiansen et al., "Relation between breast-feeding and incidence rates of insulindependent diabetes mellitus", The Lancet, vol. 2, no. 8411, pp. 1083-1086, 1984.
17. M. A. Atkinson, M. A. Bowman, K.-J. Kao et al., "Lack of immune responsiveness to bovine serum albumin in insulindependent diabetes", The New England Journal of Medicine, vol. 329, no. 25, pp. 1853-1858, 1993.
18. J. Karjalainen, J. M. Martin, M. Knip et al., "A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus", The New England Journal of Medicine, vol. 327, no. 5, pp. 302-307, 1992.
19. J. M. Martin, B. Trink, D. Daneman, H.-M. Dosch, and B. Robinson, "Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM)", Annals of Medicine, vol. 23, no. 4, pp. 447-452, 1991.
20. A. Ceriello, A. Novials, E. Ortega et al., "Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes", Diabetes Care, vol. 36, no. 12, pp. 4104-4108, 2013.
21. S. A. W. Greeley, M. Katsumata, L. Yu et al., "Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice", Nature Medicine, vol. 8, no. 4, pp. 399-402, 2002.
22. Y. Kagohashi, J. Udagawa, N. Abiru, M. Kobayashi, K. Moriyama, and H. Otani, "Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring", Diabetes, vol. 54, no. 7, pp. 2026-2031, 2005.
23. Y. Kagohashi, J. Udagawa, K. Moriyama, and H. Otani, "Maternal environment affects endogenous virus induction in the offspring of type 1 diabetes model non-obese diabetic mice", Congenital Anomalies, vol. 45, no. 3, pp. 80-84, 2005.
24. A. Jayasimhan, K. P. Mansour, and R. M. Slattery, "Advances in our understanding of the pathophysiology of type 1 diabetes: Lessons from the NOD mouse", Clinical Science, vol. 126, no. 1, pp. 1-18, 2014.
25. C. F. Verge, R. Gianani, E. Kawasaki et al., "Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies", Diabetes, vol. 45, no. 3, pp. 926-933, 1996.
26. H. Fujita, H. Fujino, and K. Nonaka, "Retrovirus-like particles in pancreatic B-cells of NOD (non-obese diabetic) mice", Biomedical Research, vol. 5, no. 1, pp. 67-70, 1984.
27. H. Tsumura, M. Miyazawa, S. Ogawa, J. Z. Wang, Y. Ito, and K. Shimura, "Detection of endogenous retrovirus antigens in NOD mouse pancreatic β-cells", Laboratory Animals, vol. 32, no. 1, pp. 86-94, 1998.
28. J. M. Norris, B. Beaty, G. Klingensmith et al., "Lack of association between early exposure to cow's milk protein and β- cell autoimmunity: diabetes autoimmunity study in the young (DAISY)", Journal of the American Medical Association, vol. 276, no. 8, pp. 609-614, 1996.
29. L. Marjamäki, S. Niinistö, M. G. Kenward et al., "Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring", Diabetologia, vol. 53, no. 8, pp. 1599-1607, 2010.
30. L. C. Stene and G. Joner, "Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study", American Journal of Clinical Nutrition, vol. 78, no. 6, pp. 1128-1134, 2003.
31. L. C. Stene, J. Ulriksen, P. Magnus, and G. Joner, "Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring", Diabetologia, vol. 43, no. 9, pp. 1093-1098, 2000.
32. C. M. Fronczak, A. E. Barón, H. P. Chase et al., "In utero dietary exposures and risk of islet autoimmunity in children", Diabetes Care, vol. 26, no. 12, pp. 3237-3242, 2003.
33. J. M. Norris, X. Yin, M. M. Lamb et al., "Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes", The Journal of the American Medical Association, vol. 298, no. 12, pp. 1420-1428, 2007.
34. J. M. Norris, "Infant and childhood diet and type 1 diabetes risk: recent advances and prospects", Current Diabetes Reports, vol. 10, no. 5, pp. 345-349, 2010.
35. M. R. Miller, X. Yin, J. Seifert et al., "Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY)", Pediatric Diabetes, vol. 12, no. 8, pp. 669-675, 2011.
36. M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, and H. Vlassara, "Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice", Diabetes, vol. 52, no. 6, pp. 1441-1448, 2003.
37. Z. Fu, J. Yuskavage, and D. Liu, "Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice", Journal of Agricultural and Food Chemistry, vol. 61, no. 18, pp. 4303-4309, 2013.
38. Y. Kagohashi, N. Abiru, M. Kobayashi, M. Hashimoto, O. Shido, and H. Otani, "Maternal dietary n-6/n-3 fatty acid ratio affects type 1 diabetes development in the offspring of non-obese diabetic mice", Congenital Anomalies, vol. 50, no. 4, pp. 212-220, 2010.
39. J. S. Skyler, "Primary and secondary prevention of type 1 diabetes", Diabetic Medicine, vol. 30, no. 2, pp. 161-169, 2013.
40. D. B. Jump, "Fatty acid regulation of gene transcription", Critical Reviews in Clinical Laboratory Sciences, vol. 41, no. 1, pp. 41-78, 2004.
41. J. N. Din, D. E. Newby, and A. D. Flapan, "Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment", British Medical Journal, vol. 328, no. 7430, pp. 30-35, 2004.
42. P. C. Calder, "n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic", Lipids, vol. 38, no. 4, pp. 343-352, 2003.
43. P. Yaqoob, "Fatty acids and the immune system: from basic science to clinical applications", Proceedings of the Nutrition Society, vol. 63, no. 1, pp. 89-104, 2004.
44. Á. Gil, "Polyunsaturated fatty acids and inflammatory diseases", Biomedicine & Pharmacotherapy, vol. 56, no. 8, pp. 388-396, 2002.
45. A. P. Simopoulos, "Omega-3 fatty acids in inflammation and autoimmune diseases", Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495-505, 2002.
46. J. J. Pestka, "N-3 Polyunsaturated fatty acids and autoimmunemediated glomerulonephritis", Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4-6, pp. 251-258, 2010.
47. M. Lumia, P. Luukkainen, H. Tapanainen et al., "Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring", Pediatric Allergy and Immunology, vol. 22, no. 8, pp. 827-835, 2011.
48. H. P. Chase, E. Lescheck, L. Rafkin-Mervis et al., "The Type 1 Diabetes Trial Net NIP Study Group. Nutritional intervention to prevent (NIP) type 1 diabetes: a pilot trial", Infant, Child, & Adolescent Nutrition, vol. 1, pp. 98-107, 2009.
49. B. I. Nwaru, M. Erkkola, M. Lumia et al., "Maternal intake of fatty acids during pregnancy and allergies in the offspring", British Journal of Nutrition, vol. 108, no. 4, pp. 720-732, 2012.
50. A. P. Simopoulos, "The importance of the ratio of omega-6/omega-3 essential fatty acids", Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 365-379, 2002.
51. P. Kankaanpää, K. Nurmela, A. Erkkilä et al., "Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy", Allergy: European Journal of Allergy and Clinical Immunology, vol. 56, no. 7, pp. 633-638, 2001.
52. R. Uauy-Dagach and P. Mena, "Nutritional role of omega-3 fatty acids during the perinatal period", Clinics in Perinatology, vol. 22, no. 1, pp. 157-175, 1995.
53. A. Fagen and J. Scheidler, "Meals to go", Journal of Renal Nutrition, vol. 10, no. 4, pp. 215-230, 2000.
54. S. Schmid, K. Koczwara, S. Schwinghammer, V. Lampasona, A.-G. Ziegler, and E. Bonifacio, "Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice", Clinical Immunology, vol. 111, no. 1, pp. 108-118, 2004.
55. Y. Kagohashi and H. Otani, "Dietary EFA ratio of the gestation period affects type 1 diabetes development in the offspring", Experimental Animals, vol. 60, p. S122, 2011.
56. Y. Kagohashi, H. Kameyama, Y. Fujihara et al., "The effect of dietary EFA ratio and composition on the development of type 1 diabetes in the offspring of NODmice", Congenital Anomalies, vol. 51, no. 4, p. A18, 2011.
57. G. Kuriya, T. Uchida, S. Akazawa et al., "Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse", Diabetologia, vol. 56, no. 8, pp. 1773-1780, 2013.
58. M. J. Allen, Y. Y. Fan, J. M. Monk et al., "N-3 PUFAs reduce T-helper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4+ T cells", The Journal of Nutrition, vol. 144, no. 8, pp. 1306-1313, 2014.
59. J. M. Norris, M. Kroehl, T. E. Fingerlin et al., "Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young", Diabetologia, vol. 57, no. 2, pp. 295-304, 2014.
60. Y. Kagohashi and H. Otani, "Dietary EFA ratio of the gestation period affects type 1 diabetes development in the offspring", Experimental Animals, vol. 60, no. 3, p. S122, 2011.
61. D. J. P. Barker and C. Osmond, "Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales", The Lancet, vol. 1, no. 8489, pp. 1077-1081, 1986.
62. P. P. Silveira, A. K. Portella, M. Z. Goldani, and M. A. Barbieri, "Developmental origins of health and disease (DOHaD)", Jornal de Pediatria, vol. 83, no. 6, pp. 494-504, 2007.
63. Y. Kagohashi and H. Otani, "Maternal intake of essential fatty acid affects development of type 1 diabetes in the offspring", Journal of Lipid Nutrition, vol. 22, no. 1, pp. 35-43, 2013.
64. Y. Kagohashi and H. Otani, "Maternal environmental factors and the development of type 1 diabetes", Diabetes and Pregnancy, vol. 7, pp. 23-29, 2007.